Other

Pharmacologic Treatment Strategies for Nonalcoholic Steatohepatitis

Volume: 49, Issue: 1, Pages: 105 - 121
Published: Mar 1, 2020
Abstract
Nonalcoholic fatty liver disease (NAFLD) is a common form of liver disease, associated with features of the metabolic syndrome. Nonalcoholic steatohepatitis (NASH), the aggressive subtype of NAFLD, can cause progressive fibrosis leading to cirrhosis. With the obesity epidemic, there is an increased health care burden from NASH, one of the most common causes of liver transplantation in the United States. There currently are no Food and Drug...
Paper Details
Title
Pharmacologic Treatment Strategies for Nonalcoholic Steatohepatitis
Published Date
Mar 1, 2020
Volume
49
Issue
1
Pages
105 - 121
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.